FIFTH THIRD BANCORP

Bank

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 35527 CINCINNATI, OH

Position in LCTX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$6,026,000

-$1,242,000 QoQ

Shares Held

4,600,000

0.0% QoQ

Ownership

1.82%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 130 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIFTH THIRD BANCORP holds $202,001,766 across 150 Biotechnology names. LCTX ranks #10 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	81,898	$40,681,193
2	REGN	Regeneron Pharmaceuticals, Inc.	29,244	$18,234,803
3	TECH	BIO-TECHNE Corp	117,371	$8,292,261
4	VCEL	Vericel Corp	185,051	$8,232,918
5	KYMR	Kymera Therapeutics, Inc.	65,659	$7,529,117
6	HALO	Halozyme Therapeutics, Inc.	95,681	$7,488,951
7	BBIO	BridgeBio Pharma, Inc.	87,238	$6,497,486
8	RARE	Ultragenyx Pharmaceutical Inc.	193,236	$6,452,150

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,026,000	4,600,000	0.0%	Shares	Defined	2026-08-05
2026-03-31	$7,268,000	4,600,000	+323843.7%	Shares	Defined	2026-05-01
2022-09-30	$1,604	1,420	0.0%	Shares	Defined	2022-10-25
2022-06-30	$2,243	1,420	0.0%	Shares	Defined	2022-08-04
2022-03-31	$2,186	1,420	0.0%	Shares	Defined	2022-04-19
2021-12-31	$3,479	1,420	0.0%	Shares	Defined	2022-02-01
2021-09-30	$3,578	1,420	0.0%	Shares	Defined	2021-10-15
2021-06-30	$4,047	1,420	0.0%	Shares	Defined	2021-08-06
2021-03-31	$3,337	1,420	0.0%	Shares	Defined	2021-05-07
2020-12-31	$2,499	1,420	0.0%	Shares	Defined	2021-02-16
2020-09-30	$1,334	1,420	0.0%	Shares	Defined	2020-11-09
2020-06-30	$1,235	1,420	0.0%	Shares	Defined	2020-08-05
2020-03-31	$1,178	1,420	—	Shares	Defined	2020-05-05
No filing history on record for this holder in this stock.